FDA Adverse Event Injury Summary report: N

FINELINE II

MDR report key: 3053257 · Received April 11, 2013

Report

Report Number
2124215-2013-05212
Event Type
Injury
Date Received
April 11, 2013
Date of Event
January 23, 2013
Report Date
March 15, 2013
Manufacturer
CPI - DEL CARIBE
Product Code
NVN
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

THE LEAD REMAINS IN SERVICE WITHOUT FURTHER COMPLICATIONS. AS NO FURTHER INFORMATION CONCERNING THIS REPORT IS EXPECTED, OUR INVESTIGATION IS COMPLETE. THIS INVESTIGATION WILL BE UPDATED SHOULD FURTHER INFORMATION BE PROVIDED.

Description of Event or Problem · 1

BOSTON SCIENTIFIC RECEIVED INFORMATION THAT THIS RIGHT VENTRICULAR (RV) LEAD WAS REPOSITIONED DUE TO DISLODGEMENT FIVE DAYS POST-IMPLANT. NO ADVERSE PATIENT EFFECTS WERE REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
155440 FINELINE II IMPLANTABLE LEAD NVN CPI - DEL CARIBE 4471

Patients

Seq Age Sex Outcome Treatment
1 71 YR Hospitalization| L| R (B)(4)| 5076| 4471